Table 4.
Median months from first referral to diagnosis by mode of referral and tumour type
| Mode of referral | Type I iEOC | Type II iEOC | iEOC | Borderline | ||||
|---|---|---|---|---|---|---|---|---|
| n (%) | Median (IQR) months | n (%) | Median (IQR) months | n (%) | Median (IQR) months | n (%) | Median (IQR) months | |
| 2‐week cancer referral to gynaecological oncology | 29 (57)a | 1.5 (1.3–2.0) | 41 (34)a | 1.4 (0.7–1.9) | 70 (41) | 1.4 (1.1–2.0) | 18 (60) | 1.5 (1.1, 1.8) |
| 2‐week cancer referral to nongynaecological specialties | 5 (10) | 2.2 (1.8–2.2) | 17 (14) | 1.4 (1.2–2.5) | 22 (13) | 1.4 (1.2–2.5) | 2 (7) | 3.8 (2.0, 5.5) |
| Routine to general gynaecology | 6 (12) | 2.6 (2.1–3.3) | 10 (8) | 2.7 (2.0–3.7) | 16 (9) | 2.6 (2.0–3.7) | 3 (10) | 8.7 (1.6, 11.4) |
| Routine to nongynaecological specialtiesb | 1 (2) | – | 22 (18) | 2.3 (1.4–5.5) | 23 (13) | 2.3 (1.4–5.5) | 3 (10) | 4.6 (2.8, 7.4) |
| Accident and emergency | 10 (20) | 1.3 (0.3–2.0) | 31 (26) | 0.9 (0.5–1.7) | 41 (24) | 1.0 (0.5–1.7) | 4 (13) | 1.4 (0.9, 3.1) |
| Total referrals | 51 (100%) | 121 (100%) | 172 (100%) | 30 (100%) | ||||
iEOC, invasive epithelial ovarian cancer; IQR, interquartile range. Based on medical record data. Women with unknown mode of referral (n = 11) or who were diagnosed following an incidental finding (n = 14) are excluded.
a
P < 0.05.
b
One woman had a routine referral to clinical oncology as she was still undergoing follow up for colon cancer.